Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma

LESSONS LEARNED: Trials dedicated to metastatic uveal melanoma are needed because of the poor prognosis of this rare cancer and because its biology is distinct from that of cutaneous melanoma. Agents targeting the MEK/ERK/MAP kinase pathways are being tested. BACKGROUND. In experimental models, beva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Piperno-Neumann, Sophie, Diallo, Alhassane, Etienne-Grimaldi, Marie-Christine, Bidard, François-Clément, Rodrigues, Manuel, Plancher, Corine, Mariani, Pascale, Cassoux, Nathalie, Decaudin, Didier, Asselain, Bernard, Servois, Vincent
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4786360/
https://ncbi.nlm.nih.gov/pubmed/26911405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados